These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24384301)

  • 21. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
    Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
    J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
    Sztanek F; Seres I; Harangi M; Lőcsey L; Padra J; Paragh GJ; Asztalos L; Paragh G
    Nephrol Dial Transplant; 2012 Jul; 27(7):2866-72. PubMed ID: 22247228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M; Akca R; Sarandol E; Dilek K
    J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities.
    Rock W; Rosenblat M; Miller-Lotan R; Levy AP; Elias M; Aviram M
    J Agric Food Chem; 2008 Sep; 56(18):8704-13. PubMed ID: 18759451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.
    Rosenblat M; Volkova N; Aviram M
    Biofactors; 2014; 40(5):536-45. PubMed ID: 25230879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.
    Marsillach J; Aragonès G; Mackness B; Mackness M; Rull A; Beltrán-Debón R; Pedro-Botet J; Alonso-Villaverde C; Joven J; Camps J
    Lipids Health Dis; 2010 May; 9():46. PubMed ID: 20470383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
    Lee JH; Park JH; Lee SH; Kim JR; Cho KH
    Int J Mol Med; 2010 Jun; 25(6):945-51. PubMed ID: 20428800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.
    Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH
    Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
    Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
    Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis.
    Mahrooz A; Zargari M; Sedighi O; Shaygani H; Gohari G
    Clin Invest Med; 2012 Jun; 35(3):E144-51. PubMed ID: 22673317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low high-density lipoprotein cholesterol is not responsible for decreased paraoxonase activity in chronic renal failure.
    Varga É; Seres I; Harangi M; Kárpáti I; Koncsos P; Sztanek F; Paragh G
    Kidney Blood Press Res; 2012; 35(4):265-72. PubMed ID: 22378349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency.
    Noto H; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
    Biochem Biophys Res Commun; 2001 Nov; 289(2):395-401. PubMed ID: 11716486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraoxonase 1 (PON1) is present in postprandial chylomicrons.
    Fuhrman B; Volkova N; Aviram M
    Atherosclerosis; 2005 May; 180(1):55-61. PubMed ID: 15823275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
    Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
    Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postprandial Paraoxonase 1 Activity Following Consumption of Recommended Amounts of Mixed Meals in Healthy Males.
    Kameyama N; Maruyama C; Kotani K; Caccavello R; Gugliucci A; Matsui S; Araki R; Maruyama T
    J Atheroscler Thromb; 2016; 23(2):225-32. PubMed ID: 26447089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease.
    Rumora L; Rajković MG; Kopčinović LM; Pancirov D; Čepelak I; Grubišić TŽ
    COPD; 2014 Sep; 11(5):539-45. PubMed ID: 24831724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
    Sutherland WH; Manning PJ; de Jong SA; Allum AR; Jones SD; Williams SM
    Metabolism; 2001 Mar; 50(3):319-24. PubMed ID: 11230785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraoxonase activity in healthy, diabetic, and hemodialysis patients.
    Gbandjaba NY; Ghalim N; Hassar M; Berrougui H; Labrazi H; Taki H; Saile R; Khalil A
    Clin Biochem; 2012 Apr; 45(6):470-4. PubMed ID: 22285382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.